or
Remember me
Back
Maveropepimut-S: Phase 2 Basket Trial in Multiple Advanced Metastatic Solid Tumors
Enrollment continues for subjects with metastatic bladder cancer, liver cancer (hepatocellular carcinoma, HCC), and for the microsatellite instability high (MSI-H) tumors. IMV intends to provide a clinical update on the trial in the second half of this year.
A daily snapshot of everything from market open to close.